Actinic Keratosis (AK)

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Rubedo Life Sciences
Rubedo Life SciencesCA - Sunnyvale
1 program
1
RLS-1496 1.0% creamPhase 1/21 trial
Active Trials
NCT07340697RecruitingEst. May 2026

Clinical Trials (1)

NCT07340697Rubedo Life SciencesRLS-1496 1.0% cream

Evaluate RLS-1496 Topical Cream for Actinic Keratosis

Start: Jan 2026Est. completion: May 2026
Phase 1/2Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space